170 related articles for article (PubMed ID: 15304042)
1. Comparison of thrombin-catalyzed fibrin polymerization and factor XIIIa-catalyzed cross-linking of fibrin among three recombinant variant fibrinogens, gamma 275C, gamma 275H, and gamma 275A.
Hirota-Kawadobora M; Terasawa F; Suzuki T; Tozuka M; Sano K; Okumura N
J Thromb Haemost; 2004 Aug; 2(8):1359-67. PubMed ID: 15304042
[TBL] [Abstract][Full Text] [Related]
2. Recombinant fibrinogen, gamma275Arg-->Cys, exhibits formation of disulfide bond with cysteine and severely impaired D:D interactions.
Ishikawa S; Hirota-Kawadobora M; Tozuka M; Ishii K; Terasawa F; Okumura N
J Thromb Haemost; 2004 Mar; 2(3):468-75. PubMed ID: 15009465
[TBL] [Abstract][Full Text] [Related]
3. An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links.
Park R; Ping L; Song J; Seo JY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2013 Feb; 109(2):199-206. PubMed ID: 23224113
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of recombinant Bbeta15C and Bbeta15A fibrinogens demonstrates that Bbeta15G residue plays important roles in FPB release and in lateral aggregation of protofibrils.
Hirota-Kawadobora M; Kani S; Terasawa F; Fujihara N; Yamauchi K; Tozuka M; Okumura N
J Thromb Haemost; 2005 May; 3(5):983-90. PubMed ID: 15869595
[TBL] [Abstract][Full Text] [Related]
5. B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'.
Okumura N; Terasawa F; Haneishi A; Fujihara N; Hirota-Kawadobora M; Yamauchi K; Ota H; Lord ST
J Thromb Haemost; 2007 Dec; 5(12):2352-9. PubMed ID: 17922804
[TBL] [Abstract][Full Text] [Related]
6. Substitution of the gamma-chain Asn308 disturbs the D:D interface affecting fibrin polymerization, fibrinopeptide B release, and FXIIIa-catalyzed cross-linking.
Okumura N; Gorkun OV; Terasawa F; Lord ST
Blood; 2004 Jun; 103(11):4157-63. PubMed ID: 14764520
[TBL] [Abstract][Full Text] [Related]
7. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).
Mukai S; Ikeda M; Takezawa Y; Sugano M; Honda T; Okumura N
Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395
[TBL] [Abstract][Full Text] [Related]
8. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
9. Analysis of fibrinogen variants at gamma387Ile shows that the side chain of gamma387 and the tertiary structure of the gammaC-terminal tail are important not only for assembly and secretion of fibrinogen but also for lateral aggregation of protofibrils and XIIIa-catalyzed gamma-gamma dimer formation.
Kani S; Terasawa F; Yamauchi K; Tozuka M; Okumura N
Blood; 2006 Sep; 108(6):1887-94. PubMed ID: 16705085
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
[TBL] [Abstract][Full Text] [Related]
11. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
Liu CZ; Shih MH; Tsai PJ
Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
[TBL] [Abstract][Full Text] [Related]
12. Severely impaired polymerization of recombinant fibrinogen gamma-364 Asp --> His, the substitution discovered in a heterozygous individual.
Okumura N; Gorkun OV; Lord ST
J Biol Chem; 1997 Nov; 272(47):29596-601. PubMed ID: 9368024
[TBL] [Abstract][Full Text] [Related]
13. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
[TBL] [Abstract][Full Text] [Related]
14. The presence of gamma' chain impairs fibrin polymerization.
Gersh KC; Nagaswami C; Weisel JW; Lord ST
Thromb Res; 2009 Jul; 124(3):356-63. PubMed ID: 19138790
[TBL] [Abstract][Full Text] [Related]
15. Evidence that heterodimers exist in the fibrinogen Matsumoto II (gamma308N-->K) proband and participate in fibrin fiber formation.
Okumura N; Terasawa F; Fujita K; Fujihara N; Tozuka M; Koh CS
Thromb Res; 2002 Aug; 107(3-4):157-62. PubMed ID: 12431483
[TBL] [Abstract][Full Text] [Related]
16. Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness.
Allan P; Uitte de Willige S; Abou-Saleh RH; Connell SD; Ariëns RA
J Thromb Haemost; 2012 Jun; 10(6):1072-80. PubMed ID: 22463367
[TBL] [Abstract][Full Text] [Related]
17. The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen.
Gorkun OV; Veklich YI; Weisel JW; Lord ST
Blood; 1997 Jun; 89(12):4407-14. PubMed ID: 9192765
[TBL] [Abstract][Full Text] [Related]
18. Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens.
Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N
Int J Lab Hematol; 2020 Apr; 42(2):190-197. PubMed ID: 31957968
[TBL] [Abstract][Full Text] [Related]
19. [Functional analysis of heterozygous plasma dysfibrinogens derived from two families of gammaArg275Cys and three families of gammaArg275His, and haplotype analysis for these families].
Kamijyo Y; Hirota-Kawadobora M; Fujihara N; Wakabayashi S; Matsuda K; Yamauchi K; Terasawa F; Okumura N; Honda T
Rinsho Byori; 2009 Jul; 57(7):651-8. PubMed ID: 19708534
[TBL] [Abstract][Full Text] [Related]
20. Strategy for recombinant multichain protein synthesis: fibrinogen B beta-chain variants as thrombin substrates.
Lord ST; Strickland E; Jayjock E
Biochemistry; 1996 Feb; 35(7):2342-8. PubMed ID: 8652575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
